Diacomit Powder, For Suspension
Product Images NDC 68418-7941

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Diacomit (NDC 68418-7941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocodex, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 mg Capsule Carton (500 mg Cap Carton)

Packaging label for Diacomit 500 mg capsule (stiripentol) by Biocodex, Inc. The label displays the product name, active ingredient, dosage form, and strength. It includes directions for use, warnings, storage instructions, and pharmacist dispensing information. The package contains 60 capsules and is marked Rx only. Manufacturer information notes Biocodex in Gentilly, France, with distribution in San Mateo, CA. A barcode is present on the label.*

FDA Label Image

500 mg Capsule 1 (500mg Cap Label1)

Diacomit 500 mg capsule label showing the active ingredient stiripentol. The label includes dispensing instructions for pharmacists to provide a Medication Guide. The package contains 60 capsules and the labeler is BioCodex, Inc. The label features a barcode and placeholders for lot number and expiration date.*

FDA Label Image

500 mg Capsule Label 2 (500mg Cap Label2)

Diacomit 500 mg (stiripentol) oral capsules label showing a bottle with 60 capsules. The label indicates prescription only and instructs pharmacists to dispense the enclosed medication guide to patients. The product is labeled by Biocodex, Inc.*

FDA Label Image

500 mg Capsule Label 3 (500mg Cap Label3)

Drug facts panel for Diacomit capsules 500 mg stiripentol. It includes active ingredient details, directions to swallow whole with water during meals, storage instructions (20 to 25°C in a dry place, protect from light), and warnings to consult full prescribing information. Manufacturer and distributor details are also provided.*

FDA Label Image

500 mg Powder Carton (500mg Powder Carton)

Diacomit 500 mg packet (stiripentol) oral suspension carton label by Biocodex, Inc. The label indicates 60 packets per carton and includes pharmacist instructions to dispense the enclosed Medication Guide to patients. The packaging features branding graphics and essential drug information, including active ingredient and storage instructions.*

FDA Label Image

500 mg Powder Label (500mg Powder Label)

Diacomit 500 mg packet (stiripentol) oral suspension label by Biocodex, Inc. The label includes dosing and administration cautions, phenylketonurics warning, storage instructions (20 to 25°C), and preparation advice to mix the powder in water before use. It also notes the product is prescription only and manufactured by Biocodex France.*

FDA Label Image

Capsule Carton (Cap Carton)

Diacomit 250 mg (stiripentol) oral capsules packaging label, displaying a box template with branding and product information. The label indicates it contains 60 capsules, is for prescription use only, and is manufactured by Biocodex, Inc. Instructions note dispensing an enclosed medication guide to patients. Dosage and storage directions appear on the side panel alongside a barcode.*

FDA Label Image

Capsule 1 (Cap Label1)

Diacomit 250 mg (stiripentol) oral capsules packaging label showing a quantity of 60 capsules. The label includes instructions to dispense the enclosed medication guide to each patient and is labeled Rx only. The product is manufactured by Biocodex, Inc.*

FDA Label Image

Capsule 2 (Cap Label2)

Diacomit 250 mg capsules label showing the oral dosage form containing stiripentol. The label indicates 60 capsules per bottle, with the labeler named BIOCODEX, INC. The packaging includes instructions for pharmacists to dispense the enclosed Medication Guide and displays an Rx Only symbol.*

FDA Label Image

Capsule 3 (Cap Label3)

Drug information panel for Diacomit capsules containing 250 mg stiripentol. It includes directions to swallow whole with water during a meal, warnings to consult full prescribing info, storage instructions at 20 to 25°C and protection from light, and manufacturer and distributor details (Biocodex, France and USA).*

FDA Label Image

Figure 1 (Figure1)

A bar chart comparing the proportion of patients (%) by percent reduction from baseline in tonic-clonic and clonic seizure frequency between placebo (blue bars) and Diacomit 50 mg/kg/day (orange bars). Categories on the x-axis range from less than 0 to 75 to 100 percent reduction, showing distinct differences in response rates between placebo and Diacomit groups.*

FDA Label Image

Formula (Formula)

Chemical structure diagram of stiripentol, the active ingredient of Diacomit capsules. The structure highlights an asymmetric carbon marked with an asterisk, showing detailed molecular bonds and groups including a benzodioxole moiety and multiple methyl groups.*

FDA Label Image

Powder Carton (Powder Carton)

Diacomit 250 mg/packet (stiripentol) oral suspension carton label by Biocodex, Inc. The label indicates the medication is for oral suspension, includes 60 packets, and is for prescription use only. It instructs pharmacists to dispense the enclosed Medication Guide to patients. The packaging also lists manufacturer details and storage instructions.*

FDA Label Image

Powder Label (Powder Label)

Diacomit 250 mg packet (stiripentol) oral suspension packaging label. The label includes the proprietary and generic names, dosage strength, and route of administration. It indicates the product is Rx only and is labeled by Biocodex, Inc. Additional safety and preparation instructions, storage conditions, and manufacturer details are provided on the label.*

FDA Label Image

Step 1 (Step1)

An instructional illustration showing powder being poured from a capsule into a small cup containing 100 mL of liquid, indicating the preparation method for oral administration.*

FDA Label Image

Step 3 (Step3)

An instructional illustration depicting a hand shaking or agitating a small rectangular packet or sachet, indicated by movement lines around the packet. No text or branding visible.*

FDA Label Image

Step 4 (Step4)

An instructional diagram showing a pair of scissors cutting a foil blister pack, likely indicating how to open or separate individual doses of a medication.*

FDA Label Image

Step 5 (Step5)

An instructional illustration showing a hand pouring granules or powder from a packet into a small cup containing liquid, suggesting preparation or administration of a medication in a liquid form.*

FDA Label Image

Step 6 (Step6)

An instructional diagram showing a hand stirring a solution in a cup with a spoon. The image demonstrates the action of mixing a substance, likely related to medication preparation or administration guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.